Skip to main content

Table 1 The concentrations of SFN and TPL at a 50% inhibition rate against Huh-7 cells for different formulations and the corresponding CI (n = 3)

From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma

Formulations

Concentration of SFN (nM)

Concentration of TPL (nM)

CI50

SFN@CPLCNPs

2350.93

  

TPL@CPLCNPs

 

8.91

 

(SFN + TPL)@LCNPs

22.49

2.25

0.26

(SFN + TPL)@PLCNPs

12.03

1.20

0.14

(SFN + TPL)@CLCNPs

7.61

0.76

0.09

(SFN + TPL)@CPLCNPs

5.44

0.54

0.06